Aveanna Healthcare (AVAH) Insider JR Sells $8M of Stock

Insider Robert Williams sold 1 million shares of Aveanna Healthcare for $8 million on June 24, 2026.

Reviewed by automated data checks against the source filing. How we make and check alerts

Williams Robert JR sold 1,000,000 shares of Aveanna Healthcare Holdings Inc. ($AVAH) at an average price of $8, worth about $8 million, on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.

Since the trade, $AVAH is up 4.6% after 1 week, up 11.6% after 1 month and up 45.7% to date (from the $8.47 close on Jun 24, 2026).

Find the original: AVAH Form 4 filings on SEC EDGAR

AVAH Aveanna Healthcare Holdings Inc.
$12.34 +52.72% year to date
Daily close · Oct 16, 2026

Key Points

  • Robert Williams sold 1 million shares of Aveanna Healthcare for $8 million on June 24, 2026, at a price of $8 each.
  • Aveanna Healthcare shares are currently trading at $8.48, slightly below their previous close of $13.67.
  • Analysts maintain a positive outlook, with a consensus recommendation of 'buy' and a mean price target of $14.6.

Get $AVAH trade alerts by text

We text you when insiders, Congress or big funds trade $AVAH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Aveanna Healthcare Holdings Inc. alert may contain errors. Disclosures

Insider Buying and Selling at Aveanna Healthcare Holdings Inc.

On June 24, 2026, insider Robert Williams sold 1 million shares of Aveanna Healthcare Holdings Inc. (NasdaqGS: AVAH) for $8 million. The shares were sold at a price of $8 each. This sale comes as the stock trades at $8.48, reflecting a notable drop from its previous close of $13.67.

What Changed in Williams' Position

Williams' sale of 1 million shares indicates a significant move from his previous holdings. After this transaction, it’s clear that his stake in the company has decreased. This sale is part of a broader trend, as other insiders have also sold shares on the same day.

Other Institutional Activity

No other funds reported changes in their positions regarding Aveanna Healthcare in this filing period. This lack of institutional activity means that Williams' sale stands out as a key event for investors tracking insider movements.

How AVAH Stock Has Traded

Aveanna Healthcare's stock is currently trading at $8.48, which is below its 50-day moving average of $11.64 and significantly lower than its 52-week high of $14.71. The stock's recent performance may raise questions among investors, especially with this insider selling.

Recent Earnings

Aveanna Healthcare reported revenue of approximately $2.6 billion, with a 13.7% growth year-over-year. The company has a net margin of about 10.6%, indicating a solid profitability level. Its next earnings report is scheduled for November 5, 2026, which may provide further insights into the company's performance and future outlook.

Insider Buying and Selling at Aveanna Healthcare Holdings Inc.

On June 24, 2026, alongside Robert Williams, Paul Vigano also sold 1 million shares at the same price of $8 each, totaling another $8 million. Additionally, LLC J.H. Whitney Equity Partners VII sold 919,389 shares for about $7.36 million. This collective insider activity on the same day may signal a shift in sentiment among company insiders.

Analysts Set New Price Targets

Analysts maintain a generally positive outlook on Aveanna Healthcare. On September 14, 2026, JP Morgan maintained a 'Neutral' rating with a price target of $15. Barclays also kept its 'Overweight' rating with a target of $15. The consensus recommendation remains a 'buy' with a mean target price of $14.6, reflecting confidence in the company's growth potential despite recent insider selling.

What AVAH Does

Aveanna Healthcare is a diversified home care platform that provides pediatric and adult healthcare services across the United States. The company's focus on patient-centered care allows individuals to receive necessary services while remaining in their homes, which is increasingly important in today’s healthcare landscape.

What to Watch at AVAH

Investors will be looking closely at the upcoming earnings report on November 5, 2026, to gauge the company's financial health and any potential impacts from the recent insider selling. Remember, the reported trades reflect past positions and may not represent current holdings or sentiments among insiders.

Source: Williams Robert JR's Form 4 filing on $AVAH (Jun 24, 2026). Find the original filing: AVAH Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $AVAH trade alerts by text